NLG919

NLG919

Catalog Number:
L002369172APE
Mfr. No.:
APE-A4373
Price:
$284
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          NLG919 is a novel and orally-bioavailable small-molecule inhibitor of indoleamine 2,3-dioxygenase (IDO) pathway, a crucial pathway involved in allergic inflammation that mediates immunosuppressive effects through metabolization of tryptophan (Trp) to kynurenine and affects differentiation and proliferation of T cells through inducing downstream signaling via GCN2, mTOR and AHR, with values of inhibition constant Ki and half maximal effective concentration EC50 of 7 nM and 75 nM respectively. Due to the established correlation of IDO pathway with various malignancies, the IDO pathway inhibition as well as its desirable pharmacological and biological properties potentiates NLG919 to be used for the treatment of immunosuppression associated with cancer.

      • Properties
        • Alternative Name
          1-cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5-yl)ethanol
          CAS Number
          1402836-58-1
          Molecular Formula
          C18H22N2O
          Molecular Weight
          282.38
          Appearance
          A solid
          Purity
          98.17%
          Solubility
          insoluble in H2O; insoluble in EtOH; ≥47.7 mg/mL in DMSO
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Sun C, He D, et al. "Bifunctional fusion proteins derived from Tumstatin and 4-1BBL for targeted cancer therapy." Mol Pharm. 2018 Dec 19. PMID:30565463

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.